A new class of molecules against cancer cells refractory to standard treatments

Current anticancer treatments essentially target the primary tumour cells that proliferate quickly, but do not effectively eliminate specific cancer cells able to adapt to existing treatments and which exhibit high metastatic potential1. Yet metastases are responsible for 70% of cancer deaths.

A French research team from Institut Curie, the CNRS and Inserm has just developed a new class of small molecules that bring about the destruction of cell membranes, and hence triggers cell death. Led…

Continue Reading


News Source: www.sciencedaily.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *